Abstract

Pimecrolimus 1% cream, a topical calcineurin inhibitor approved for treatment of eczema in children aged ≥2 years, is often used when concerns arise

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call